Is a complete PPBT research report available?

No complete published report is available for Purple Biotech Ltd (PPBT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Purple Biotech Ltd (PPBT)

NASDAQ: PPBT · USD

$0.92

-0.00 (-0.4%)· Recorded snapshot

Market cap	10.4M
Net income (ttm)	-24.5M
EPS (ttm)	-$2.76
Shares out	2.2B
Volume	9,926
Beta	-0.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -24.5M
EPS (ttm): -$2.76
Market cap: 10.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001614744
Company name	Purple Biotech Ltd
Country	Israel
Country code	US
CUSIP number	74638P307
Earnings date	2026-11-13
Earnings time	bmo
Employees	10
Employees change	1
Employees growth	11.11%
Enterprise value	$4.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	US74638P3073
Last 10-K release date	2026-03-19
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split date	2026-03-02
Last stock split type	Reverse
Market cap	$10.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	Yes
Price	$0.92
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PPBT
Website	https://purple-biotech.com

Metric

Value

Amount currency

USD

CIK code

0001614744

Company name

Purple Biotech Ltd

Country

Israel

Country code

CUSIP number

74638P307

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

Employees growth

11.11%

Enterprise value

$4.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

Industry

Biotechnology

Is primary listing

Is SPAC

ISIN number

US74638P3073

Last 10-K release date

2026-03-19

Last earnings date

2026-08-07

Last refreshed

2026-10-28

Last stock split date

2026-03-02

Last stock split type

Reverse

Market cap

$10.4M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Yes

Price

$0.92

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

PPBT

Website

https://purple-biotech.com

Metric	Value
Earnings yield	-299.48%
FCF / EV yield	-165.99%
FCF yield	-74.03%
P/B ratio	0.86x
Price / tangible book value	2.14x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-299.48%

FCF / EV yield

-165.99%

FCF yield

-74.03%

P/B ratio

0.86x

Price / tangible book value

2.14x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-2.4M
Profitable years	11
ROA	-20.31%
ROA (5Y)	-19.58%
ROCE	-63.68%
ROE	-111.13%
ROE (5Y)	-51.72%
ROIC	-22.15%

Metric

Value

Profit per employee

$-2.4M

Profitable years

ROA

-20.31%

ROA (5Y)

-19.58%

ROCE

-63.68%

ROE

-111.13%

ROE (5Y)

-51.72%

ROIC

-22.15%

Metric	Value
EPS growth years	0
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-4,000
Depreciation and amortization	$46,000
EBIT	$-7.9M
EBITDA	$-7.8M
EPS	$-2.76
FCF per share	$-0.00
Financing cash flow	$7.9M
Free cash flow	$-7.8M
Free cash flow minus SBC	$-8.1M
Gross profit	$-59,000
Investing cash flow	$314,000
Net borrowing	$-250,000
Net cash flow	$500,000
Net income	$-24.5M
Operating cash flow minus SBC	$-8.1M
Operating income	$-7.9M
Stock-based compensation	$317,000

Metric

Value

Capital expenditures

$-4,000

Depreciation and amortization

$46,000

EBIT

$-7.9M

EBITDA

$-7.8M

EPS

$-2.76

FCF per share

$-0.00

Financing cash flow

$7.9M

Free cash flow

$-7.8M

Free cash flow minus SBC

$-8.1M

Gross profit

$-59,000

Investing cash flow

$314,000

Net borrowing

$-250,000

Net cash flow

$500,000

Net income

$-24.5M

Operating cash flow minus SBC

$-8.1M

Operating income

$-7.9M

Stock-based compensation

$317,000

Metric	Value
Book value per share	$0.01
Debt / equity	0.01
Interest coverage	-876.22
Long-term assets	$7.6M
Long-term liabilities	$170,000
Net cash (debt)	$6M
Net cash / market cap	56.95%
Net cash growth	2.67%
Net debt / equity	-0.49
Piotroski F-Score	2
Property, plant and equipment	$216,000
Shareholders' equity	$12.2M
Tangible book value	$4.9M
Tangible book value per share	$0.00
Total assets	$14.2M
Total cash	$6.1M
Total debt	$134,000
Total liabilities	$2M
WACC	1.29%

Metric

Value

Book value per share

$0.01

Debt / equity

0.01

Interest coverage

-876.22

Long-term assets

$7.6M

Long-term liabilities

$170,000

Net cash (debt)

$6M

Net cash / market cap

56.95%

Net cash growth

2.67%

Net debt / equity

-0.49

Piotroski F-Score

Property, plant and equipment

$216,000

Shareholders' equity

$12.2M

Tangible book value

$4.9M

Tangible book value per share

$0.00

Total assets

$14.2M

Total cash

$6.1M

Total debt

$134,000

Total liabilities

$2M

WACC

1.29%

Metric	Value
Current assets	$6.6M
Current liabilities	$1.8M
Current ratio	3.7
Net working capital	$-1.2M
Quick ratio	3.42
Working capital	$4.8M

Metric

Value

Current assets

$6.6M

Current liabilities

$1.8M

Current ratio

3.7

Net working capital

$-1.2M

Quick ratio

3.42

Working capital

$4.8M

Metric	Value
Buyback yield / dilution	-267.67%
Dividend yield	0%
Shareholder yield	-267.67%

Metric

Value

Buyback yield / dilution

-267.67%

Dividend yield

Shareholder yield

-267.67%

Metric	Value
10Y price change	-99.99%
10Y return CAGR	-59.12%
10Y total return	-99.99%
150-day SMA	$2.33
1D price change	-0.43%
1M price change	-38.41%
1M total return	-38.41%
1W price change	-14.29%
1W total return	-14.29%
1Y price change	-84.38%
1Y return CAGR	-84.39%
1Y total return	-84.38%
20-day SMA	$1.25
200-day SMA	$3.07
3M price change	-35.42%
3M total return	-35.42%
3Y price change	-99.66%
3Y return CAGR	-84.93%
3Y total return	-99.66%
50-day SMA	$1.48
50-day SMA vs 200-day SMA	50under200
52-week high	$14.10
52-week high date	2025-10-29
52-week low	$0.91
52-week low date	2026-10-28
5Y price change	-99.89%
5Y return CAGR	-74.56%
5Y total return	-99.89%
6M price change	-79.74%
6M total return	-79.74%
All-time high	$13,900.00
All-time high date	2016-05-16
All-time low	$0.91
All-time low date	2026-10-28
Average true range (ATR)	$0.11
Average volume	21.4K
Beta (5Y)	-0.55
Change from 52-week high	-93.48%
Change from 52-week low	1.1%
Change from all-time high	-99.99%
Change from all-time low	2.2%
Change from open	0%
Day's gap	-0.43%
Dollar volume	$9,132
High price	$0.92
Low price	$0.92
Monthly RSI	31.56
Open price	$0.92
Premarket change	1.97%
Premarket close	$0.92
Premarket price	$0.94
Premarket volume	316
Previous close	$0.92
Price vs 150-day SMA	-60.09%
Price vs 20-day SMA	-25.42%
Price vs 200-day SMA	-69.74%
Price vs 50-day SMA	-37.16%
Relative volume	0.46
RSI	25.11
Sharpe ratio	-0.99
Sharpe ratio (3Y)	-0.89
Sharpe ratio (5Y)	-0.77
Sortino ratio	-1.55
Sortino ratio (3Y)	-1.51
Sortino ratio (5Y)	-1.25
Volume	9.9K
Weekly RSI	22.99
YTD price change	-85.86%
YTD total return	-85.86%

Metric

Value

10Y price change

-99.99%

10Y return CAGR

-59.12%

10Y total return

-99.99%

150-day SMA

$2.33

1D price change

-0.43%

1M price change

-38.41%

1M total return

-38.41%

1W price change

-14.29%

1W total return

-14.29%

1Y price change

-84.38%

1Y return CAGR

-84.39%

1Y total return

-84.38%

20-day SMA

$1.25

200-day SMA

$3.07

3M price change

-35.42%

3M total return

-35.42%

3Y price change

-99.66%

3Y return CAGR

-84.93%

3Y total return

-99.66%

50-day SMA

$1.48

50-day SMA vs 200-day SMA

50under200

52-week high

$14.10

52-week high date

2025-10-29

52-week low

$0.91

52-week low date

2026-10-28

5Y price change

-99.89%

5Y return CAGR

-74.56%

5Y total return

-99.89%

6M price change

-79.74%

6M total return

-79.74%

All-time high

$13,900.00

All-time high date

2016-05-16

All-time low

$0.91

All-time low date

2026-10-28

Average true range (ATR)

$0.11

Average volume

21.4K

Beta (5Y)

-0.55

Change from 52-week high

-93.48%

Change from 52-week low

1.1%

Change from all-time high

-99.99%

Change from all-time low

2.2%

Change from open

Day's gap

-0.43%

Dollar volume

$9,132

High price

$0.92

Low price

$0.92

Monthly RSI

31.56

Open price

$0.92

Premarket change

1.97%

Premarket close

$0.92

Premarket price

$0.94

Premarket volume

316

Previous close

$0.92

Price vs 150-day SMA

-60.09%

Price vs 20-day SMA

-25.42%

Price vs 200-day SMA

-69.74%

Price vs 50-day SMA

-37.16%

Relative volume

0.46

RSI

25.11

Sharpe ratio

-0.99

Sharpe ratio (3Y)

-0.89

Sharpe ratio (5Y)

-0.77

Sortino ratio

-1.55

Sortino ratio (3Y)

-1.51

Sortino ratio (5Y)

-1.25

Volume

9.9K

Weekly RSI

22.99

YTD price change

-85.86%

YTD total return

-85.86%

Metric	Value
Float	3.2B
Float percentage	148.77%
Shares change (QoQ)	16.7%
Shares change (YoY)	267.67%
Shares held by insiders	0.32%
Shares held by institutions	12.24%
Shares outstanding	2.2B
Short % of shares	1.11%
Short ratio	0 days

Metric

Value

Float

3.2B

Float percentage

148.77%

Shares change (QoQ)

16.7%

Shares change (YoY)

267.67%

Shares held by insiders

0.32%

Shares held by institutions

12.24%

Shares outstanding

2.2B

Short % of shares

1.11%

Short ratio

0 days

Purple Biotech Ltd (PPBT)

Price

Financial snapshot

Fair-value bridge

Latest news · PPBT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PPBT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PPBT

Frequently asked questions